Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-02-27
2007-02-27
Kaushal, Sumesh (Department: 1633)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S325000, C435S455000, C536S023100, C536S023500
Reexamination Certificate
active
10787382
ABSTRACT:
The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
REFERENCES:
patent: 5831023 (1998-11-01), Capon et al.
patent: 0 186 098 (1986-07-01), None
patent: 0 322 870 (1989-07-01), None
patent: 0 414 355 (1991-02-01), None
patent: 0 759 468 (1997-02-01), None
patent: 0 875 251 (1998-11-01), None
patent: WO 99/61618 (1999-12-01), None
Juengst BMJ, 326:1410-11, 2003.
Brown et al BLOOD 100(4):133-1140, 2002.
Rosenberg et al, Gene Therapist, Heal Thyself. SCIENCE 287:1751, 2000.
Verma, Gene Therapy: beyond 2000. Mol. Ther.. 1:493, 2000.
Friedmann, Principles for Human Gene Therapy Studies. SCIENCE 287(5461):2163-4, 2000.
Anderson WF, Human Gene Therapy. NATURE 392:25-30, 1998.
Verma et al, Gene Therapy-promises, problems prospects. NATURE 389:239-242, 1997.
Touchette, Gene Therapy: Not ready for prime time. Nat. Med. 2(1) 7-8, 1996.
Ngo, Computational complexity Protein structure prediction and the Levinthal paradox in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al. (eds.), Birkhauser Boston: Boston, MA, pp. 433 and 492-495, 1994).
Rudinger Characteristics of amino acids as components of a peptide hormone sequence (in Peptide Hormones, Parsons (ed.), University Park Press: Baltimore, MD, pp. 1-7, 1976).
Adachi et al Am J Physiol Cell Physiol 275: C623-C633, 1998.
McKenzie, Pharma. Ther. 88:143-151, 2000.
Watts et al, Int. J. Parasitology 29:1149-1163, 1999.
Yang et al J Interferon Cytokine Res 21(6):361-7, 2001.
Gough et al.,The EMBO Journal, vol. 4, No. 3, 1985, pp. 645-653.
Graf et al.,Eur. J. Immunol., vol. 22, 1992, pp. 3191-3194.
Grimaldi et al.,Journal of Immunology, vol. 149, No. 12, 1992, pp. 3921-3926.
Hannum et al.,Nature, vol. 368, 1994, pp. 643-648.
Heussler et al.,Gene, vol. 114, 1992, pp. 273-278.
Himmler et al.,Journal of Interferon Research, vol. 7, 1987, pp. 173-183.
Hirano et al.,Immunology, vol. 90, 1997, pp. 294-300.
Hollenbaugh et al.,The EMBO Journal, vol. 11, No. 12, 1992, pp. 4313-4321.
Inumaru et al.,Immunology and Cell Biology, vol. 73, 1995, pp. 474-476.
Johnson et al.,J. Mol. Biol., vol. 233, 1993, pp. 716-738.
Kelley et al.,Nucleic Acids Research, vol. 13, No. 3, 1985, pp. 805-823.
Lakkis et al.,Biochemical and Biophysical Research Communications, vol. 197, No. 2, 1993, pp. 612-618.
Leong et al.,Veterinary Immunology and Immunopathology, vol. 21, 1989, pp. 261-278.
Lerner et al., GenBank Accession No. U39634, submitted Oct. 27, 1995.
Lerner et al., GenBank Accession No. AAB42052 (U39634.1), submitted Oct. 27, 1995.
Lyman et al.,Blood, vol. 83, No. 10, 1994, pp. 2795-2801.
Lyman et al.,Oncogene, vol. 10, 1995, pp. 149-157.
Lyman et al.,Cell, vol. 75, 1993, pp. 1157-1167.
Lyman et al.,Oncogene, vol. 11, 1995, pp. 1165-1172.
McClanahan et al.,Blood, vol. 88, No. 9, 1996, pp. 3371-3382.
McInnes et al.,Gene, vol. 105, 1991, pp. 275-279.
McKenzie et al.,Proc. Natl. Acad. Sci. USA, vol. 90, 1993, pp. 3735-3739.
Mertens et al.,Immunogenetics, vol. 42, 1995, pp. 430-431.
Minty et al.,Nature, vol. 362, 1993, pp. 248-250.
Nagata et al.Nature, vol. 287, 1980, pp. 401-408.
Nakamura et al.,Biosci. Biotech. Biochem., vol. 56, No. 2, 1992, pp. 211-214.
Nash et al.,Blood, vol. 78, No. 4, 1991, pp. 930-937.
Navarro et al.,J. Gen. Virol.vol. 70, 1989, pp. 1381-1389.
O'Brien et al.,Immunology and Cell Biology, vol. 69, 1991, pp. 51-55.
Osorio et al.,Vaccine, vol. 17, 1999, pp. 1109-1116.
Padrid et al.,AJVR, vol. 59, No. 10, 1998, pp. 1263-1269.
Patterson et al.,Journal of Clinical Investigation, vol. 44, No. 1, 1965, pp. 140-148.
Seow et al.,Gene, vol. 124, 1993, pp. 291-293.
Sideras et al.,Adv. Exp. Med. Biol., vol. 213, 1987, pp. 227-236.
Stamenkovic et al.,The EMBO Journal, vol. 8, No. 5, 1989, pp. 1403-1410.
Torres et al.,Journal of Immunology, vol. 148, No. 2, 1992, pp. 620-626.
Wong et al.,Science, vol. 228, 1985, pp. 810-815.
Yokota et al.,Proc. Natl. Acad. Sci. USA, vol. 83, 1986, pp. 5894-5898.
Zhou et al., GenBank Accession No. L12991.
Van Der Kaaij, et al., 1999, “Immunogenetics,” vol. 49, pp. 142-143.
Ueda, et al., 1993,Journal of Veterinary Medical Science, vol. 55, No. 2, pp. 251-258, XP001001462.
Armitage et al.,Seminars in Immunology, vol. 5, 1993, pp. 401-412.
Armitage et al.,Nature, vol. 357, 1992, pp. 80-82.
Azuma et al.,Nucleic Acids Research, vol. 14, No. 22, 1986, pp. 9149-9158.
Brown et al.,Journal of Immunology, vol. 142, No. 2, 1989, pp. 679-687.
Cantrell et al.,Proc. Natl. Acad. Sci. USA, vol. 82, 1985, pp. 6250-6254.
Daugherty et al.,Journal of Interferon Research, vol. 4, 1984, pp. 635-643.
Dion et al.,Biochemical and Biophysical Research Communications, vol. 138, No. 2, 1986, pp. 826-834.
Drexler,Leukemia, vol. 10, 1996, pp. 588-599.
Feng et al.,J. Mol. Evol., vol. 21, 1985, pp. 112-125.
Gauchat et al.,Res. Immunol., vol. 145(3), Mar.-Apr. 1994, pp. 240-249.
Gauchat et al.,FEBS 11964, vol. 315, No. 3, 1993, pp. 259-266.
Goeddel et al.,Nature, vol. 290, 1981, pp. 20-26.
McCall Catherine A.
Weber Eric R.
Yang Shumin
Heska Corporation
Heska Corporation
Kaushal Sumesh
LandOfFree
Cannie IL-5 nucleic acid molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cannie IL-5 nucleic acid molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cannie IL-5 nucleic acid molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850726